Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00905021 · ClinicalTrials.gov registry record · Phase 1
Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer
A Phase 1 study, sponsored by Baylor Breast Care Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT00905021: Clinical Trial Phase 1 study, sponsored by Baylor Breast Care Center.
NCT00905021 is a Phase 1 study that was terminated before completion, run by Baylor Breast Care Center. The registered enrollment target is 4 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00905021, a Phase 1 study, was terminated before completion, sponsored by Baylor Breast Care Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
The investigators want to find out if the treatments used in this study are helpful to patients that are diagnosed with hormone receptor positive metastatic breast cancer. The investigators want to also look at any side effects that could happen while patients are on the study treatments. The investigators want to see if there are any changes that could show us if your cancer is responding to the study treatments.
Primary Outcome
Time from the first day of treatment to date of progression in weeks
Interventions
- DRUG Exemestane
- DRUG Sutent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2010-03 |
| Est. Completion | 2012-02 |
| Phase | Phase 1 |
Why NCT00905021 stopped before completion
NCT00905021 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Exemestane is the first listed.
NCT00905021 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00905021 about?
NCT00905021 is a clinical study titled "Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer". The investigators want to find out if the treatments used in this study are helpful to patients that are diagnosed with hormone receptor positive metastatic breast cancer. The investigators want to also look at any side effects that could happen while patients are on the study treatments. The invest...
What is the current status of trial NCT00905021?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2010-03. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00905021?
The interventions under investigation include: Exemestane (DRUG), Sutent (DRUG).
Who is sponsoring clinical trial NCT00905021?
This trial is sponsored by Baylor Breast Care Center, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00905021's enrollment target sits among peer trials
4 1995th of 2000 higher than 2 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia